Submitted by Anonymous (not verified) on 14 November 2025 - 11:30
Human medicines European public assessment report (EPAR): Enflonsia, clesrovimab, Status: Opinion
Source:
Human medicines European public assessment report (EPAR): Enflonsia, clesrovimab, Status: Opinion